|Articles|May 1, 2016
- Pharmaceutical Executive-05-01-2016
- Volume 36
- Issue 5
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Steering the Change: GSK's Jack Baileyover 10 years ago
Pharma’s Big Push for Valueover 10 years ago
Pharm Exec at the Vantage Pointover 10 years ago
Pharma Under Pressure to Curb Opioid Abuseover 10 years ago
Country Report: Franceover 10 years ago
Pharma Under Fire for Driving "Opioid Abuse Epidemic"Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
GSK Advances mRNA Flu Vaccine to Phase III
2
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
3
Beyond Traditional Strategy Consulting Firms: Why MBA Students Should Consider Turnaround, Restructuring Consulting
4
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion
5